US5614610A
(en)
*
|
1984-12-21 |
1997-03-25 |
Oncogen |
Tumor immunotherapy using anti-idiotypic antibodies
|
US4795634A
(en)
*
|
1986-03-14 |
1989-01-03 |
Aphton Corporation |
Method for contraception by immunization against the zona pellucida
|
DE3609271A1
(de)
*
|
1986-03-19 |
1987-09-24 |
Boehringer Mannheim Gmbh |
Verfahren und reagenz zum nachweis von autoimmunerkrankungen, arzneimittel zur behandlung von autoimmunerkrankungen sowie hierzu geeignete antiparatypische antikoerper
|
US5180660A
(en)
*
|
1987-02-19 |
1993-01-19 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
US5217895A
(en)
*
|
1987-02-19 |
1993-06-08 |
Nissin Shokuhin Kabushiki Kaisha |
Monoclonal anti-idiotypic antibodies specific for anti-T4 antibodies and cross-reactive with HIV
|
US5140105A
(en)
*
|
1987-02-19 |
1992-08-18 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
US5169752A
(en)
*
|
1987-02-19 |
1992-12-08 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
CA1341277C
(en)
*
|
1987-03-16 |
2001-07-31 |
Roland Keith Mcgready |
Anti-paratopic antibody and a method of its manufacture
|
AU1436188A
(en)
*
|
1987-04-08 |
1988-10-13 |
Synbiotics Corp. |
Method for the early selection of anti-idiotype antibody internal images
|
US5004699A
(en)
*
|
1987-11-20 |
1991-04-02 |
Sri International |
Method to detect fungi and yeasts
|
US4910131A
(en)
*
|
1987-12-23 |
1990-03-20 |
Mellman Ira S |
Idiotype and anti-idiotype antibodies useful in virus detection
|
USRE39760E1
(en)
|
1988-03-31 |
2007-08-07 |
International Bio-Immune Systems Inc. |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
|
US5688657A
(en)
*
|
1988-03-31 |
1997-11-18 |
International Bio-Immune Systems, Inc. |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
|
JPH03501209A
(ja)
*
|
1988-05-17 |
1991-03-22 |
フェロン、ソルダノ |
抗ヒト高分子量メラノーマ関連抗原に対する抗イディオタイプ抗体
|
JP3095169B2
(ja)
*
|
1988-10-17 |
2000-10-03 |
キャンサー リサーチ キャンペーン テクノロジー リミティド |
抗イディオタイプ抗体による抗腫瘍応答の誘導
|
US7252929B2
(en)
|
1989-02-09 |
2007-08-07 |
United States Of America, As Represented By The Secretary, Dept Of Health & Human Services |
Methods for identifying alpha PDGFR agonists and antagonists
|
US5468468A
(en)
*
|
1989-02-09 |
1995-11-21 |
The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services |
Method for making a monoclonal antibody, monoclonal antibodies to α PD
|
US6228600B1
(en)
|
1992-07-20 |
2001-05-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Immunoassays for the alpha platelet-derived growth factor receptor
|
US5693622A
(en)
*
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
US5703055A
(en)
*
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US6673776B1
(en)
|
1989-03-21 |
2004-01-06 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
|
US6867195B1
(en)
|
1989-03-21 |
2005-03-15 |
Vical Incorporated |
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
|
DE69034078T2
(de)
|
1989-03-21 |
2004-04-01 |
Vical, Inc., San Diego |
Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
|
US5091302A
(en)
*
|
1989-04-27 |
1992-02-25 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
|
ES2113371T3
(es)
*
|
1989-11-16 |
1998-05-01 |
Univ Duke |
Transformacion de celulas epidermicas de tejidos animales con la ayuda de particulas.
|
US5436163A
(en)
*
|
1989-12-01 |
1995-07-25 |
The Blood Center Of Southeastern Wisconsin |
Polymorphism of human platelet membrane glycoprotein IIb and diagnostic applications thereof
|
US5264554A
(en)
*
|
1990-01-19 |
1993-11-23 |
The Blood Center Of Southeastern Wisconsin, Inc. |
Platelet cell adhesion molecule and variants thereof
|
US20030186913A1
(en)
*
|
1990-03-21 |
2003-10-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
US6228844B1
(en)
|
1991-11-12 |
2001-05-08 |
Vical Incorporated |
Stimulating vascular growth by administration of DNA sequences encoding VEGF
|
US6706694B1
(en)
|
1990-03-21 |
2004-03-16 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
HUT62803A
(en)
*
|
1990-05-22 |
1993-06-28 |
Univ California |
Process for producing antigen-specific, high affinity human monoclonal antibody
|
US5419904A
(en)
*
|
1990-11-05 |
1995-05-30 |
The Regents Of The University Of California |
Human B-lymphoblastoid cell line secreting anti-ganglioside antibody
|
DE4129849A1
(de)
*
|
1991-02-14 |
1992-08-27 |
Boehringer Mannheim Gmbh |
Monoklonale antikoerper gegen humane pankreas-inselzellen
|
US5264556A
(en)
*
|
1991-04-18 |
1993-11-23 |
Rougier Inc. |
Monoclonal antibodies for measuring okadaic acid
|
DE4130786A1
(de)
*
|
1991-09-16 |
1993-03-18 |
Symbiotec Gmbh |
Peptide zur herstellung von mitteln zur diagnose und therapie von systemischen lupus
|
DE69334191T2
(de)
*
|
1992-03-13 |
2008-11-27 |
bioMérieux B.V. |
Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
|
US6008327A
(en)
*
|
1992-03-13 |
1999-12-28 |
Akzo Nobel, N.V. |
Peptides and nucleic acid sequences related to the Epstein Barr virus
|
US20030144473A1
(en)
*
|
1992-09-16 |
2003-07-31 |
Michael Zeppezauer |
Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
|
US5476784A
(en)
*
|
1993-04-06 |
1995-12-19 |
Rice; Peter A. |
Gonococcal anti-idiotypic antibodies and methods and compositions using them
|
FR2703788B1
(fr)
*
|
1993-04-09 |
1996-12-20 |
Jacques Toledano |
Dispositif et procede anti-idiotype de detection immunologique.
|
WO1995007102A1
(en)
*
|
1993-09-09 |
1995-03-16 |
Duke University |
A method of promoting cellular function
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
ATE407207T1
(de)
|
1994-11-02 |
2008-09-15 |
Trophix Pharm Inc |
Natrium-ionenkanäle spezifisch für das periphäre nervensystem, dna welche diese kodiert, wirkstoff-suche und methoden zu deren herstellung und verwendung
|
IL114615A0
(en)
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
US7750137B2
(en)
*
|
1995-09-01 |
2010-07-06 |
Millennium Pharmaceuticals, Inc. |
Mucosal vascular addressins
|
US7803904B2
(en)
*
|
1995-09-01 |
2010-09-28 |
Millennium Pharmaceuticals, Inc. |
Mucosal vascular addressing and uses thereof
|
US6551593B1
(en)
*
|
1995-02-10 |
2003-04-22 |
Millennium Pharmaceuticals, Inc. |
Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
|
US6605274B1
(en)
|
1995-04-11 |
2003-08-12 |
The Regents Of The University Of California |
Method for in vivo regulation of cardiac muscle contractility
|
ATE208403T1
(de)
*
|
1995-05-26 |
2001-11-15 |
Merck Patent Gmbh |
Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
|
WO1998008090A1
(en)
*
|
1995-06-06 |
1998-02-26 |
Epigen, Inc. |
Anti-idiotypic antibodies to an epiglycanin
|
US6074641A
(en)
*
|
1995-06-07 |
2000-06-13 |
Rice; Peter A. |
Gonococcal anti-idiotypic antibodies and methods and compositions using them
|
US7147851B1
(en)
*
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
SI1019500T1
(sl)
|
1997-01-15 |
2007-02-28 |
Yeda Res & Dev |
Proteini, ki vezejo receptor 1 za ifn, dna, ki jih kodira, in postopki za regulacijo celicnega odziva na interferone
|
EP2428250A1
(de)
|
1998-07-13 |
2012-03-14 |
Genetronics, Inc. |
Haut- und muskelgerichtete Gentherapie mit hilfe eines gepulsten elektrischen Felds
|
US7922709B2
(en)
*
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
DK1048725T3
(da)
|
1999-04-27 |
2005-08-22 |
Transgene Sa |
Fremgangsmåde til fremstilling af pattedyrcellelinjer
|
US20020002270A1
(en)
*
|
1999-06-16 |
2002-01-03 |
Raymond P. Zinkowski |
Purified antigen for alzheimer's disease, and methods of obtaining and using same
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
US6838250B2
(en)
*
|
2000-03-31 |
2005-01-04 |
Ortho-Clinical Diagnostics, Inc. |
Immunoassay for C-reactive protein
|
AU2001261557B2
(en)
|
2000-05-12 |
2005-06-30 |
Amgen Inc. |
Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
|
US20020026373A1
(en)
*
|
2000-08-24 |
2002-02-28 |
Sudesh Kamath |
Methods and systems for online express ordering of goods and services
|
US20030026806A1
(en)
*
|
2000-10-27 |
2003-02-06 |
Amgen Inc. |
Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
|
MXPA04000134A
(es)
|
2001-06-26 |
2005-06-06 |
Abgenix Inc |
Anticuerpos para ligandos de osteoprotegerina.
|
AU2002316384A1
(en)
*
|
2001-06-26 |
2003-03-03 |
Photomed Technologies, Inc. |
Multiple wavelength illuminator
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
US8986944B2
(en)
|
2001-10-11 |
2015-03-24 |
Aviva Biosciences Corporation |
Methods and compositions for separating rare cells from fluid samples
|
US8980568B2
(en)
|
2001-10-11 |
2015-03-17 |
Aviva Biosciences Corporation |
Methods and compositions for detecting non-hematopoietic cells from a blood sample
|
DE10151511A1
(de)
|
2001-10-18 |
2003-05-08 |
Basf Lynx Bioscience Ag |
ee3-Proteinfamilie und zugrundeliegende DNA-Sequenzen
|
AU2003243139B2
(en)
*
|
2002-04-05 |
2007-06-21 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
WO2004060911A2
(en)
*
|
2002-12-30 |
2004-07-22 |
Amgen Inc. |
Combination therapy with co-stimulatory factors
|
US7892563B2
(en)
*
|
2003-05-20 |
2011-02-22 |
Wyeth Holdings Corporation |
Methods for treatment of severe acute respiratory syndrome (SARS)
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
EP2135619A1
(de)
|
2003-12-10 |
2009-12-23 |
Millennium Pharmaceuticals, Inc. |
Humanisierte Anti-CCR2-Antikörper und Anwendungsverfahren
|
IL160033A0
(en)
*
|
2004-01-25 |
2004-06-20 |
Transpharma Medical Ltd |
Transdermal delivery system for polynucleotides
|
EP1730196B1
(de)
|
2004-03-12 |
2010-12-22 |
Vasgene Therapeutics, Inc. |
Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum
|
CA2563334A1
(en)
*
|
2004-04-16 |
2005-11-17 |
Genentech, Inc. |
Assay for antibodies
|
WO2008101133A2
(en)
*
|
2007-02-14 |
2008-08-21 |
Cedars-Sinai Medical Center |
Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
|
EP1819827B1
(de)
*
|
2004-12-08 |
2010-08-11 |
Cedars-Sinai Medical Center |
Verfahren zur diagnose von morbus crohn
|
CN101218256B
(zh)
|
2005-03-23 |
2017-04-19 |
根马布股份公司 |
用于治疗多发性骨髓瘤的cd38抗体
|
JP4699840B2
(ja)
*
|
2005-08-31 |
2011-06-15 |
ローム株式会社 |
バイオチップ及び免疫分析方法
|
JP5097557B2
(ja)
*
|
2005-12-22 |
2012-12-12 |
ローム株式会社 |
免疫測定装置及び方法
|
CN101583722A
(zh)
|
2006-07-14 |
2009-11-18 |
阿维瓦生物科学股份有限公司 |
从生物学样品检测稀有细胞的方法和组合物
|
US20100267052A1
(en)
*
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US20080300170A1
(en)
*
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
US20090203602A1
(en)
*
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
US20100190162A1
(en)
*
|
2007-02-26 |
2010-07-29 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
|
WO2008137762A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Cedars-Sinai Medical Center |
Methods of diagnosis and treatment of crohn's disease
|
US20100015156A1
(en)
*
|
2007-03-06 |
2010-01-21 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
US8486640B2
(en)
|
2007-03-21 |
2013-07-16 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
|
US20090182035A1
(en)
*
|
2007-04-11 |
2009-07-16 |
Alcon Research, Ltd. |
Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
|
JP2010523695A
(ja)
*
|
2007-04-11 |
2010-07-15 |
アルコン リサーチ, リミテッド |
アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのTNFαのインヒビターおよび抗ヒスタミン薬の使用
|
WO2008134569A2
(en)
*
|
2007-04-26 |
2008-11-06 |
Cedars-Sinai Medical Center |
Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
|
JP5710978B2
(ja)
|
2007-11-08 |
2015-04-30 |
ネオジェニックス オンコロジー, インコーポレイテッド |
結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原
|
DK2240238T3
(da)
|
2008-01-17 |
2019-07-22 |
Inovio Pharmaceuticals Inc |
Elektroporationssystem med variabel strømtæthed og en enkelt nål
|
CA2736799A1
(en)
|
2008-08-25 |
2010-03-11 |
Burnham Institute For Medical Research |
Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
|
US20110177969A1
(en)
*
|
2008-10-01 |
2011-07-21 |
Cedars-Sinai Medical Center |
The role of il17rd and the il23-1l17 pathway in crohn's disease
|
US20110189685A1
(en)
*
|
2008-10-22 |
2011-08-04 |
Cedars-Sinai Medical Center |
Methods of using jak3 genetic variants to diagnose and predict crohn's disease
|
WO2010062960A2
(en)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
AU2010300421B2
(en)
*
|
2009-10-01 |
2014-01-23 |
Alcon Research, Ltd. |
Olopatadine compositions and uses thereof
|
CN102933231B
(zh)
|
2010-02-10 |
2015-07-29 |
伊缪诺金公司 |
Cd20抗体及其用途
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CA3079122A1
(en)
|
2010-03-26 |
2011-09-29 |
Trustees Of Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20110287458A1
(en)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Method and composition for the diagnosis and monitoring of inflammatory diseases
|
WO2011154453A1
(en)
|
2010-06-09 |
2011-12-15 |
Genmab A/S |
Antibodies against human cd38
|
WO2011163401A2
(en)
|
2010-06-22 |
2011-12-29 |
Neogenix Oncology, Inc. |
Colon and pancreas cancer specific antigens and antibodies
|
CA2812556C
(en)
|
2010-09-23 |
2023-02-14 |
Xue-Ping Wang |
Colon and pancreas cancer peptidomimetics
|
WO2012071561A2
(en)
|
2010-11-23 |
2012-05-31 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of anemia
|
WO2012149320A1
(en)
|
2011-04-29 |
2012-11-01 |
Bristol-Myers Squibb Company |
Ip-10 antibody dosage escalation regimens
|
WO2012151247A2
(en)
|
2011-05-02 |
2012-11-08 |
Millennium Pharmaceuticals, Inc. |
FORMULATION FOR ANTI-α4β7 ANTIBODY
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
EP2522689A1
(de)
|
2011-05-13 |
2012-11-14 |
Universität Bayreuth |
Nicht virale Transfektionssysteme
|
EP2523002A1
(de)
|
2011-05-13 |
2012-11-14 |
Universität Bayreuth |
Verwendung von magnetischen Nanoteilchen als intrazelluläre Liftsysteme
|
EA036545B1
(ru)
|
2011-05-25 |
2020-11-20 |
Иннейт Фарма, С.А. |
Анти-kir антитела для лечения воспалительных заболеваний
|
CN104040350B
(zh)
*
|
2011-12-19 |
2016-05-18 |
弗·哈夫曼-拉罗切有限公司 |
用于检测多特异性结合物的游离结合搭档的方法
|
WO2013192504A1
(en)
|
2012-06-22 |
2013-12-27 |
The Trustees Of Dartmouth College |
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CN109793893B
(zh)
|
2012-09-07 |
2023-05-26 |
达特茅斯大学理事会 |
用于诊断和治疗癌症的vista调节剂
|
EP3677310A1
(de)
|
2012-10-08 |
2020-07-08 |
St. Jude Children's Research Hospital |
Therapien auf der basis der steuerung der stabilität und funktion regulatorischer t-zellen über eine neuropilin-1:semaphorin-achse
|
EP3336104A1
(de)
|
2012-12-28 |
2018-06-20 |
Precision Biologics, Inc. |
Humanisierte monoklonale antikörper und verfahren zur verwendung zur diagnose und behandlung von darm- und pankreaskrebs
|
AU2014241162A1
(en)
|
2013-03-27 |
2015-10-22 |
Cedars-Sinai Medical Center |
Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
|
KR102363220B1
(ko)
|
2013-07-05 |
2022-02-15 |
젠맵 에이/에스 |
인간화 또는 키메라 cd3 항체
|
WO2015010108A1
(en)
|
2013-07-19 |
2015-01-22 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP4043493A1
(de)
|
2013-12-24 |
2022-08-17 |
Janssen Pharmaceutica NV |
Anti-vista-antikörper und -fragmente
|
US11123426B2
(en)
|
2014-06-11 |
2021-09-21 |
The Trustees Of Dartmouth College |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
ME03665B
(de)
|
2014-07-11 |
2020-10-20 |
Genmab As |
Axl-bindende antikörper
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
DK3310800T3
(da)
|
2015-06-19 |
2022-02-28 |
Centurion Biopharma Corp |
Leveringssystem til styret lægemiddelfrigivelse
|
MX2017016647A
(es)
|
2015-06-24 |
2019-04-25 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
MX2018009800A
(es)
|
2016-02-12 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
CA3020848A1
(en)
|
2016-04-15 |
2017-10-19 |
Janssen Pharmaceuticals, Inc. |
Anti-human vista antibodies and use thereof
|
CA3035081A1
(en)
|
2016-09-02 |
2018-03-08 |
Dana-Farber Cancer Institute, Inc. |
Composition and methods of treating b cell disorders
|
AU2018375787B2
(en)
|
2017-11-30 |
2023-02-23 |
Ladrx Corporation |
Albumin-binding prodrugs of auristatin E derivatives
|
BR112020010989A2
(pt)
|
2017-11-30 |
2020-11-17 |
Centurion Biopharma Corporation |
sistemas de distribuição de droga à base de maitansinoide
|
MX2020009379A
(es)
|
2018-03-12 |
2020-10-14 |
Genmab As |
Anticuerpos.
|
CA3129834A1
(en)
|
2019-02-15 |
2020-08-20 |
Integral Molecular, Inc. |
Claudin 6 antibodies and uses thereof
|
WO2020168024A1
(en)
|
2019-02-15 |
2020-08-20 |
Integral Molecular, Inc. |
Antibodies comprising a common light chain and uses thereof
|
MX2023003749A
(es)
|
2020-10-02 |
2023-04-24 |
Genmab As |
Anticuerpos capaces de unirse al receptor huerfano 2 similar a tirosina-cinasa receptora (ror2) y anticuerpos biespecificos que se unen a ror2 y al cumulo de diferenciacion 3 (cd3).
|
IL311141A
(en)
|
2021-09-06 |
2024-04-01 |
Genmab As |
Antibodies capable of binding to CD27, their variants and uses thereof
|
US12049502B2
(en)
|
2022-11-30 |
2024-07-30 |
Integral Molecular, Inc. |
Antibodies directed to claudin 6, including bispecific formats thereof
|